New chief medical officer appointed at Linnaeus Group

No comment 86 views

The Linnaeus Group has appointed a number one professor of feline drugs as its chief medical officer.

Séverine Tasker has been appointed to the newly created position, which can oversee the event and execution of the Linnaeus Group’s medical goals for the supply of high quality drugs in all of its practices and hospitals throughout the UK.

New position

An RCVS-recognised specialist in inside drugs and feline drugs, Prof Tasker can be a European veterinary specialist in small animal inside drugs. She has been on the educational workers of the College of Bristol since 2002.

In her new position, Prof Tasker may also have accountability for the group’s medical training technique and programmes resembling Linnaeus’ graduate academy, and its rising variety of residency programmes and internships.

READ  Early hen fee for Digital Congress

Develop potential

Prof Tasker stated: “It’s a terrific privilege to be becoming a member of Linnaeus on this new and thrilling position. I wish to use my expertise in academia to assist clinicians all through the Linnaeus Group to develop their full potential in a supportive setting.

“I’m notably motivated by the corporate’s forward-thinking values in management, innovation and medical care, and am wanting ahead to working with workers in a mutual dedication to excellence.

“It’s a very thrilling time for Linnaeus and I’m delighted to be enjoying a component within the additional growth of the group.”

قالب وردپرس

author
Author: 

Leave a reply "New chief medical officer appointed at Linnaeus Group"

This site uses Akismet to reduce spam. Learn how your comment data is processed.